Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care

Launched by CASE COMPREHENSIVE CANCER CENTER · Jun 24, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care," is aimed at improving the way patients receive support and resources during their cancer care journey. The researchers want to see if a new integrated approach, which includes navigation services to help guide patients through the healthcare system, can lead to better health outcomes and enhance the quality of life for individuals facing cancer.

The trial is currently looking for participants who are between the ages of 65 and 74 and have either had a cancer screening that showed concerning results or have been referred to a specific diagnostic clinic. Specifically, they are seeking individuals who identify as African American or Hispanic, or who live in areas with certain socioeconomic challenges. Anyone interested in participating will need to be willing to complete an informed consent form, which is a document that explains the study and ensures that participants understand what it involves. If you decide to participate, you can expect to receive personalized support and assistance as you navigate your cancer care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • There are two levels of criteria for inclusion.
• • First, investigators will identify individuals who have either had a cancer screening with a suspicious finding (ie. requires diagnostic follow-up) or those individuals who are referred to the UH Seidman Diagnostic Clinic (led by Co-I Hoehn).
• • Within that group, investigators will recruit those who identify as African American, Hispanic, or living in a prioritized geography as defined by zip code ADI\>=75%ile for state
• Exclusion Criteria:
• • Any participant who is not willing or able to complete an informed consent form will not be eligible for this study